scispace - formally typeset
H

Hao Zhou

Researcher at Huazhong University of Science and Technology

Publications -  12
Citations -  79

Hao Zhou is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Mitophagy. The author has an hindex of 1, co-authored 1 publications receiving 2 citations.

Papers
More filters
Journal ArticleDOI

Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance

TL;DR: In this article , a review describes recent research on the protective effects of MQS in ICM and highlights promising therapeutic targets, which may enable the development of novel preventive and therapeutic strategies aimed at overcoming the challenge of myocardial ischemia and its cardiovascular sequelae.
Journal ArticleDOI

Mitochondrial quality control mechanisms as molecular targets in diabetic heart.

TL;DR: In this paper , the authors describe the involvement of MQC in the pathogenesis of diabetic cardiomyopathy, and discuss the potential targeted therapies that could be applied to improve MqC during diabetic cardio-myopathy.
Journal ArticleDOI

PGAM5-Mediated PHB2 Dephosphorylation Contributes to Diabetic Cardiomyopathy by Disrupting Mitochondrial Quality Surveillance

TL;DR: In this paper , the authors observed that cardiac expression of phosphoglycerate mutase 5 (PGAM5), a mitochondrial Ser/Thr protein phosphatase, is upregulated in mice with streptozotocin-induced DCM.
Journal ArticleDOI

Structural and Functional Analysis of the CAPS SNARE-Binding Domain Required for SNARE Complex Formation and Exocytosis.

TL;DR: The results suggest that CAPS-1 facilitates SNARE complex formation via the DAMH domain in a manner dependent on sequential and cooperative interaction with Munc13-1 and SNARE proteins.
Journal ArticleDOI

TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury.

TL;DR: In this article , the role of transmembrane BAX inhibitor motif containing 6 (TMBIM6) in septic cardiomyopathy (SCM) was evaluated using mice.